Class information for:
Level 1: CLINICAL TRIAL RISK//CONTINUOUS IMPROVEMENT//STRATEGIE IND

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
16529 584 31.7 57%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1294 8163 FOOD AND DRUG LAW JOURNAL//GENERIC SUBSTITUTION//DIRECT TO CONSUMER ADVERTISING

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CLINICAL TRIAL RISK Author keyword 8 100% 1% 5
2 CONTINUOUS IMPROVEMENT Address 3 57% 1% 4
3 STRATEGIE IND Address 3 100% 1% 3
4 EXPLORATORY STAGE Author keyword 2 67% 0% 2
5 RESEARCH AND DEVELOPMENT PRODUCTIVITY Author keyword 2 67% 0% 2
6 ANESTHESIOL PERIOPERAT PAIN MEDMRB Address 1 100% 0% 2
7 CLIN BIOCHEMJOSEPH WOLF LEBOVIC Address 1 100% 0% 2
8 CONFIRMATORY STAGE Author keyword 1 100% 0% 2
9 DISCOVERY SYNTHET CHEM Address 1 50% 0% 2
10 GLOBAL DRUG DISCOVERY TARGET DISCOVERY Address 1 50% 0% 2

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class		 LCSH search Wikipedia search
1 CLINICAL TRIAL RISK 8 100% 1% 5 Search CLINICAL+TRIAL+RISK Search CLINICAL+TRIAL+RISK
2 EXPLORATORY STAGE 2 67% 0% 2 Search EXPLORATORY+STAGE Search EXPLORATORY+STAGE
3 RESEARCH AND DEVELOPMENT PRODUCTIVITY 2 67% 0% 2 Search RESEARCH+AND+DEVELOPMENT+PRODUCTIVITY Search RESEARCH+AND+DEVELOPMENT+PRODUCTIVITY
4 CONFIRMATORY STAGE 1 100% 0% 2 Search CONFIRMATORY+STAGE Search CONFIRMATORY+STAGE
5 INTEGRATION OF CLINICAL PHARMACOLOGY 1 100% 0% 2 Search INTEGRATION+OF+CLINICAL+PHARMACOLOGY Search INTEGRATION+OF+CLINICAL+PHARMACOLOGY
6 TOPIC SPECIFIC PUBLICATIONS 1 100% 0% 2 Search TOPIC+SPECIFIC+PUBLICATIONS Search TOPIC+SPECIFIC+PUBLICATIONS
7 ACADEMIC DRUG DISCOVERY 1 40% 0% 2 Search ACADEMIC+DRUG+DISCOVERY Search ACADEMIC+DRUG+DISCOVERY
8 TC 5214 1 33% 0% 2 Search TC+5214 Search TC+5214
9 ACADEMIC RESEARCH CENTERS 1 50% 0% 1 Search ACADEMIC+RESEARCH+CENTERS Search ACADEMIC+RESEARCH+CENTERS
10 ANESTHETIC ADJUVANTS 1 50% 0% 1 Search ANESTHETIC+ADJUVANTS Search ANESTHETIC+ADJUVANTS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 PHARMACEUTICAL INNOVATION 4 39% 2% 9
2 THERAPEUTIC CATEGORY 4 75% 1% 3
3 BIG PHARMA 4 56% 1% 5
4 LEAN SIGMA 3 100% 1% 3
5 NEED US 3 60% 1% 3
6 2 PART SERIES 2 67% 0% 2
7 INVESTIGATIONAL DRUGS 2 29% 1% 6
8 ACADEMIC DRUG DISCOVERY 1 100% 0% 2
9 HAYSTACK 1 100% 0% 2
10 MISLEADING CONGRESS 1 50% 0% 2

Journals

Reviews


Title Publ. year Cit. Active
references		 % act. ref.
to same field
Models for open innovation in the pharmaceutical industry 2013 15 3 100%
Biomarker use is associated with reduced clinical trial failure risk in metastatic melanoma 2015 2 25 44%
Drug discovery in pharmaceutical industry: productivity challenges and trends 2012 50 12 67%
Is declining innovation in the pharmaceutical industry a myth? 2005 51 2 50%
Can the flow of medicines be improved? Fundamental pharmacokinetic and pharmacological principles toward improving Phase II survival 2012 82 21 29%
Virtual pharmaceutical companies: collaborating flexibly in pharmaceutical development 2014 2 10 100%
Collaborative practices for medicinal chemistry research across the big pharma and not-for-profit interface 2014 3 16 75%
Creativity, innovation and lean sigma: a controversial combination? 2011 19 15 80%
Trends in pharmaceutical targeting of clinical indications: 1930-2013 2014 1 1 100%
Translational research: the changing landscape of drug discovery 2013 7 19 58%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 CONTINUOUS IMPROVEMENT 3 57% 0.7% 4
2 STRATEGIE IND 3 100% 0.5% 3
3 ANESTHESIOL PERIOPERAT PAIN MEDMRB 1 100% 0.3% 2
4 CLIN BIOCHEMJOSEPH WOLF LEBOVIC 1 100% 0.3% 2
5 DISCOVERY SYNTHET CHEM 1 50% 0.3% 2
6 GLOBAL DRUG DISCOVERY TARGET DISCOVERY 1 50% 0.3% 2
7 HEAD CLIN BIOCHEM 1 100% 0.3% 2
8 TUFTS STUDY DRUG DEV 1 13% 1.2% 7
9 DECS 1 17% 0.7% 4
10 ARGENTINEAN COUNCIL SCI TECH CONICET 1 50% 0.2% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000138339 ORPHAN DRUGS//RARE DISEASES//OFF ORPHAN PROD DEV
2 0.0000111825 DRUG LAG//OFF PHARMACEUT IND//JAPANESE CLINICAL TRIALS
3 0.0000104558 POLYPHARMACOLOGY//NETWORK PHARMACOLOGY//DRUG REPOSITIONING
4 0.0000088914 PROBABILITY MARKOV PROCESSES//RETURN ON QUALITY ROQ//SRI AUROBINDO EVE
5 0.0000083307 EGLETES VISCOSA//AUXEMMA ONCOCALYX//ONCOCALYXONE A
6 0.0000081597 TGN1412//SAFETY PHARMACOLOGY//REPEAT DOSE TOXICITY STUDIES
7 0.0000081571 HUMAN INTESTINAL ABSORPTION//PAMPA//LOG BB
8 0.0000080545 GENERIC SUBSTITUTION//GENERIC DRUGS//REFERENCE PRICING
9 0.0000076432 BIOCHEMICAL ENGINEERING SCIENCE//IF I CLERSE//UVB
10 0.0000073314 MANAGEMENT HEALTHCARE//RESEARCH NURSE//CLINICAL RESEARCH COORDINATORS